ICD-10 Coding for Urothelial Cancer(C67.0, C67.0B, C67.0M)
Explore detailed ICD-10 coding guidelines for urothelial cancer, including specific codes for bladder locations and essential documentation requirements.
Complete code families applicable to Urothelial Cancer
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C67.0 | Malignant neoplasm of trigone of bladder | Use when the tumor is located at the trigone of the bladder. |
|
| C67.2 | Malignant neoplasm of lateral wall of bladder | Use when the tumor is located on the lateral wall of the bladder. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutUrothelial Cancer
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Urothelial Cancer.
Omitting histologic grade in documentation
Impact
Clinical: May affect treatment decisions., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims due to insufficient documentation.
Mitigation
Ensure histologic grade is documented in all pathology reports.
Using unspecified codes when specific location is documented
Impact
Reimbursement: May lead to lower reimbursement rates., Compliance: Non-compliance with coding guidelines., Data Quality: Reduces accuracy of clinical data.
Mitigation
Always use the most specific code available based on documentation.
Specificity of Tumor Location
Impact
Audits may focus on the specificity of tumor location in documentation.
Mitigation
Train staff on the importance of documenting precise tumor locations.